v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expense:        
Research and development $ 987 $ 2,804 $ 1,791 $ 4,552
General and administrative 2,743 4,246 5,686 8,496
Settlement expense 0 0 100 0
Total operating expenses 3,730 7,050 7,577 13,048
Loss from operations (3,730) (7,050) (7,577) (13,048)
Other (income) expense:        
Interest income (2) (7) (6) (34)
Interest expense 0 0 0 230
Change in fair value of convertible note payable 5,565 23 6,530 341
Change in fair value of warrant liabilities 6,414 (18) 3,518 (9)
Convertible note default penalty 0 849 0 849
Loss on issuance of the Registered Direct Offering (see Note 9) 0 0 729 0
Loss on Consideration Shares and Warrants (see Note 9) 0 0 1,277 0
Loss on convertible note conversions 1,874 0 3,467 0
Total other expenses, net 13,851 847 15,515 1,377
Net loss $ (17,581) $ (7,897) $ (23,092) $ (14,425)
Net loss per share:        
Basic and diluted (in dollars per share) $ (0.98) $ (0.75) $ (1.34) $ (1.49)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 17,934,196 10,517,460 17,176,339 9,684,873